Michael Wittekind
Geen lopende functies
Profiel
Michael Wittekind worked as an Executive Director-Research at Amgen, Inc. from 2003 to 2007, an Associate Director at Bristol-Myers Squibb Pharmaceutical Research Institute, and a Chief Scientific Officer & Senior VP-Research at ContraFect Corp.
from 2014 to 2016.
He also worked as a Director-Process Development at Phylos, Inc. Dr. Wittekind holds a doctorate degree from the University of Wisconsin and a graduate degree from the University of Washington.
Eerdere bekende functies van Michael Wittekind
| Bedrijven | Functie | Einde |
|---|---|---|
| CONTRAFECT CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-10-2016 |
| AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2007 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | - |
Phylos, Inc.
 Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Opleiding van Michael Wittekind
| University of Wisconsin | Doctorate Degree |
| University of Washington | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Phylos, Inc.
Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Commercial Services |
| Bristol-Myers Squibb Pharmaceutical Research Institute |